China Chemical & Pharmaceutical Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
August 10, 2023 at 05:21 am EDT
Share
China Chemical & Pharmaceutical Co., Ltd. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was TWD 2,106.61 million compared to TWD 2,080.46 million a year ago. Net income was TWD 53.03 million compared to TWD 155.27 million a year ago. Basic earnings per share from continuing operations was TWD 0.18 compared to TWD 0.52 a year ago. Diluted earnings per share from continuing operations was TWD 0.18 compared to TWD 0.52 a year ago.
For the six months, sales was TWD 4,203.04 million compared to TWD 4,060.92 million a year ago. Net income was TWD 153.18 million compared to TWD 243.78 million a year ago. Basic earnings per share from continuing operations was TWD 0.52 compared to TWD 0.82 a year ago. Diluted earnings per share from continuing operations was TWD 0.51 compared to TWD 0.81 a year ago.
CHINA CHEMICAL & PHARMACEUTICAL CO., LTD. is a Taiwan-based company principally engaged in the manufacture and sales of pharmaceuticals. The products of the Company include pharmaceuticals for human, animal drugs, medical devices, daily products and nutritious food products. Pharmaceuticals for human include prescription drugs and patented medicines, among others. Medical equipment includes nursing liquid for contact lens, sphygmomanometers and manmade joints. Animal drugs include feedstuff additives and healthcare products for animals, among others. Daily products include toothpastes, shower liquid, facial masks and mouth rinses, among others. The Company operates businesses in Taiwan and Mainland China.